Double-blind, placebo-controlled study of borderline personality disorder: Olanzapine plus dialectical behavior therapy - Soler,J.; Pascual,J.C.; Campins,J.; Barrachina,J.; Puigdemont,D.; Alvarez,E.; Pérez,V. (Am J Psychiatry, 2005)